{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:38Z","timestamp":1787020358944,"version":"build-2736575974"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T00:00:00Z","timestamp":1780704000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Genomics"],"DOI":"10.1186\/s12920-026-02406-6","type":"journal-article","created":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T06:16:08Z","timestamp":1780726568000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterizing SMN1 hybrid and deletion alleles using large-scale SNP array-based SMA carrier screening"],"prefix":"10.1186","volume":"19","author":[{"given":"Noemi","family":"Vidal-Folch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Stout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Winters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devin","family":"Oglesbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Hasadsri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara L.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,6]]},"reference":[{"issue":"6","key":"2406_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1038\/nrneurol.2015.77","volume":"11","author":"I Faravelli","year":"2015","unstructured":"Faravelli I, et al. Spinal muscular atrophy\u2013recent therapeutic advances for an old challenge. Nat Rev Neurol. 2015;11(6):351\u20139.","journal-title":"Nat Rev Neurol"},{"issue":"8","key":"2406_CR2","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/nrn2670","volume":"10","author":"AH Burghes","year":"2009","unstructured":"Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci. 2009;10(8):597\u2013609.","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"2406_CR3","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/0092-8674(95)90460-3","volume":"80","author":"S Lefebvre","year":"1995","unstructured":"Lefebvre S, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80(1):155\u201365.","journal-title":"Cell"},{"issue":"3","key":"2406_CR4","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1006\/geno.1996.0147","volume":"32","author":"L Burglen","year":"1996","unstructured":"Burglen L, et al. Structure and organization of the human survival motor neurone (SMN) gene. Genomics. 1996;32(3):479\u201382.","journal-title":"Genomics"},{"issue":"11","key":"2406_CR5","doi-asserted-by":"publisher","first-page":"6307","DOI":"10.1073\/pnas.96.11.6307","volume":"96","author":"CL Lorson","year":"1999","unstructured":"Lorson CL, et al. A single nucleotide in the SMN gene regulates splicing and is responsible for spinal muscular atrophy. Proc Natl Acad Sci U S A. 1999;96(11):6307\u201311.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"2406_CR6","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1128\/MCB.01262-08","volume":"29","author":"BG Burnett","year":"2009","unstructured":"Burnett BG, et al. Regulation of SMN protein stability. Mol Cell Biol. 2009;29(5):1107\u201315.","journal-title":"Mol Cell Biol"},{"issue":"4","key":"2406_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/ng854","volume":"30","author":"L Cartegni","year":"2002","unstructured":"Cartegni L, Krainer AR. Disruption of an SF2\/ASF-dependent exonic splicing enhancer in SMN2 causes spinal muscular atrophy in the absence of SMN1. Nat Genet. 2002;30(4):377\u201384.","journal-title":"Nat Genet"},{"issue":"5","key":"2406_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1101\/gad.1884910","volume":"24","author":"S Cho","year":"2010","unstructured":"Cho S, Dreyfuss G. A degron created by SMN2 exon 7 skipping is a principal contributor to spinal muscular atrophy severity. Genes Dev. 2010;24(5):438\u201342.","journal-title":"Genes Dev"},{"key":"2406_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-319-89689-2_2","volume":"20","author":"RN Singh","year":"2018","unstructured":"Singh RN, Singh NN. Mechanism of Splicing Regulation of Spinal Muscular Atrophy Genes. Adv Neurobiol. 2018;20:31\u201361.","journal-title":"Adv Neurobiol"},{"issue":"4","key":"2406_CR10","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.2353\/ajpath.2007.070399","volume":"171","author":"J Vitte","year":"2007","unstructured":"Vitte J, et al. Refined characterization of the expression and stability of the SMN gene products. Am J Pathol. 2007;171(4):1269\u201380.","journal-title":"Am J Pathol"},{"issue":"2","key":"2406_CR11","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1086\/338627","volume":"70","author":"M Feldkotter","year":"2002","unstructured":"Feldkotter M, et al. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet. 2002;70(2):358\u201368.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"2406_CR12","doi-asserted-by":"publisher","first-page":"fcaa075","DOI":"10.1093\/braincomms\/fcaa075","volume":"2","author":"RI Wadman","year":"2020","unstructured":"Wadman RI, et al. Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy. Brain Commun. 2020;2(2):fcaa075.","journal-title":"Brain Commun"},{"issue":"3","key":"2406_CR13","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9","volume":"15","author":"B Wirth","year":"2000","unstructured":"Wirth B. An update of the mutation spectrum of the survival motor neuron gene (SMN1) in autosomal recessive spinal muscular atrophy (SMA). Hum Mutat. 2000;15(3):228\u201337.","journal-title":"Hum Mutat"},{"issue":"10","key":"2406_CR14","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1093\/hmg\/4.10.1927","volume":"4","author":"E Hahnen","year":"1995","unstructured":"Hahnen E, et al. Molecular analysis of candidate genes on chromosome 5q13 in autosomal recessive spinal muscular atrophy: evidence of homozygous deletions of the SMN gene in unaffected individuals. Hum Mol Genet. 1995;4(10):1927\u201333.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"2406_CR15","doi-asserted-by":"publisher","first-page":"e200175","DOI":"10.1212\/NXG.0000000000200175","volume":"10","author":"M Costa-Roger","year":"2024","unstructured":"Costa-Roger M, et al. Complex SMN Hybrids Detected in a Cohort of 31 Patients With Spinal Muscular Atrophy. Neurol Genet. 2024;10(4):e200175.","journal-title":"Neurol Genet"},{"issue":"1","key":"2406_CR16","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s40246-024-00676-8","volume":"18","author":"J Long","year":"2024","unstructured":"Long J, et al. Evaluating the clinical efficacy of a long-read sequencing-based approach for carrier screening of spinal muscular atrophy. Hum Genomics. 2024;18(1):110.","journal-title":"Hum Genomics"},{"issue":"5","key":"2406_CR17","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/jhg.2015.16","volume":"60","author":"Y Kubo","year":"2015","unstructured":"Kubo Y, Nishio H, Saito K. A new method for SMN1 and hybrid SMN gene analysis in spinal muscular atrophy using long-range PCR followed by sequencing. J Hum Genet. 2015;60(5):233\u20139.","journal-title":"J Hum Genet"},{"issue":"2","key":"2406_CR18","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.braindev.2020.09.005","volume":"43","author":"ETE Niba","year":"2021","unstructured":"Niba ETE, et al. Clinical phenotypes of spinal muscular atrophy patients with hybrid SMN gene. Brain Dev. 2021;43(2):294\u2013302.","journal-title":"Brain Dev"},{"issue":"2","key":"2406_CR19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/GIM.0b013e3182017c05","volume":"13","author":"S Ben-Shachar","year":"2011","unstructured":"Ben-Shachar S, et al. Large-scale population screening for spinal muscular atrophy: clinical implications. Genet Med. 2011;13(2):110\u20134.","journal-title":"Genet Med"},{"issue":"6","key":"2406_CR20","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/j.jmoldx.2020.03.001","volume":"22","author":"J Zhang","year":"2020","unstructured":"Zhang J, et al. Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women. J Mol Diagn. 2020;22(6):817\u201322.","journal-title":"J Mol Diagn"},{"issue":"2","key":"2406_CR21","first-page":"180","volume":"42","author":"X Chen","year":"2025","unstructured":"Chen X, et al. [Carrier screening and prenatal diagnosis for Spinal muscular atrophy in 17 926 women of reproductive age in Chongqing]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2025;42(2):180\u20136.","journal-title":"Zhonghua Yi Xue Yi Chuan Xue Za Zhi"},{"issue":"2","key":"2406_CR22","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1007\/s10528-024-10775-9","volume":"63","author":"H Sun","year":"2025","unstructured":"Sun H, et al. Screening of Spinal Muscular Atrophy Carriers and Prenatal Diagnosis in Pregnant Women in Yancheng, China. Biochem Genet. 2025;63(2):1541\u201350.","journal-title":"Biochem Genet"},{"issue":"12","key":"2406_CR23","doi-asserted-by":"publisher","first-page":"1753","DOI":"10.1373\/clinchem.2018.293712","volume":"64","author":"N Vidal-Folch","year":"2018","unstructured":"Vidal-Folch N, et al. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy. Clin Chem. 2018;64(12):1753\u201361.","journal-title":"Clin Chem"},{"issue":"1","key":"2406_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10048-020-00630-5","volume":"22","author":"DL Stabley","year":"2021","unstructured":"Stabley DL, et al. Detection of SMN1 to SMN2 gene conversion events and partial SMN1 gene deletions using array digital PCR. Neurogenetics. 2021;22(1):53\u201364.","journal-title":"Neurogenetics"},{"issue":"10","key":"2406_CR25","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.15537\/1658-3175.2180","volume":"24","author":"M Al-Jumah","year":"2003","unstructured":"Al-Jumah M, et al. Molecular analysis of the spinal muscular atrophy and neuronal apoptosis inhibitory protein genes in Saudi patients with spinal muscular atrophy. Saudi Med J. 2003;24(10):1052\u20134.","journal-title":"Saudi Med J"},{"issue":"5\u20136","key":"2406_CR26","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s004390050555","volume":"100","author":"JG Chang","year":"1997","unstructured":"Chang JG, et al. Molecular analysis of survival motor neuron (SMN) and neuronal apoptosis inhibitory protein (NAIP) genes of spinal muscular atrophy patients and their parents. Hum Genet. 1997;100(5\u20136):577\u201381.","journal-title":"Hum Genet"},{"issue":"3","key":"2406_CR27","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1007\/s004390000452","volume":"108","author":"I Cusco","year":"2001","unstructured":"Cusco I, et al. Characterisation of SMN hybrid genes in Spanish SMA patients: de novo, homozygous and compound heterozygous cases. Hum Genet. 2001;108(3):222\u20139.","journal-title":"Hum Genet"},{"issue":"1","key":"2406_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1631\/jzus.B0820125","volume":"10","author":"YH Liang","year":"2009","unstructured":"Liang YH, et al. Deletion analysis of SMN1 and NAIP genes in Southern Chinese children with spinal muscular atrophy. J Zhejiang Univ Sci B. 2009;10(1):29\u201334.","journal-title":"J Zhejiang Univ Sci B"},{"issue":"1","key":"2406_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/S1525-1578(10)60680-0","volume":"4","author":"S Ogino","year":"2002","unstructured":"Ogino S, et al. Spinal muscular atrophy genetic testing experience at an academic medical center. J Mol Diagn. 2002;4(1):53\u20138.","journal-title":"J Mol Diagn"},{"issue":"2","key":"2406_CR30","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1111\/j.1442-200X.2008.02665.x","volume":"51","author":"O Omrani","year":"2009","unstructured":"Omrani O, Bonyadi M, Barzgar M. Molecular analysis of the SMN and NAIP genes in Iranian spinal muscular atrophy patients. Pediatr Int. 2009;51(2):193\u20136.","journal-title":"Pediatr Int"},{"issue":"5","key":"2406_CR31","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.jmoldx.2016.05.004","volume":"18","author":"YJ Qu","year":"2016","unstructured":"Qu YJ, et al. Mutation Spectrum of the Survival of Motor Neuron 1 and Functional Analysis of Variants in Chinese Spinal Muscular Atrophy. J Mol Diagn. 2016;18(5):741\u201352.","journal-title":"J Mol Diagn"},{"issue":"1","key":"2406_CR32","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1038\/s41598-023-30449-7","volume":"13","author":"S Savad","year":"2023","unstructured":"Savad S, et al. A comprehensive overview of SMN and NAIP copy numbers in Iranian SMA patients. Sci Rep. 2023;13(1):3202.","journal-title":"Sci Rep"},{"issue":"7","key":"2406_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.braindev.2022.03.011","volume":"44","author":"Y Xu","year":"2022","unstructured":"Xu Y, et al. Copy number assessment of SMN1 based on real-time PCR with high-resolution melting: fast and highly reliable testing. Brain Dev. 2022;44(7):462\u20138.","journal-title":"Brain Dev"},{"issue":"1","key":"2406_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13023-025-03568-9","volume":"20","author":"T Kato","year":"2025","unstructured":"Kato T, et al. Genomic analysis of the SMN1 gene region in patients with clinically diagnosed spinal muscular atrophy: a retrospective observational study. Orphanet J Rare Dis. 2025;20(1):55.","journal-title":"Orphanet J Rare Dis"},{"issue":"1","key":"2406_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13073-025-01448-2","volume":"17","author":"MM Zwartkruis","year":"2025","unstructured":"Zwartkruis MM, et al. Long-read sequencing identifies copy-specific markers of SMN gene conversion in spinal muscular atrophy. Genome Med. 2025;17(1):26.","journal-title":"Genome Med"},{"issue":"12","key":"2406_CR36","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1007\/s13312-020-2085-2","volume":"57","author":"B Behera","year":"2020","unstructured":"Behera B, Kumar A. Spinal Muscular Atrophy Type 1 With Exon 8 Deletion and Bilateral Optic Atrophy. Indian Pediatr. 2020;57(12):1191.","journal-title":"Indian Pediatr"},{"issue":"5","key":"2406_CR37","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1002\/ana.410440522","volume":"44","author":"A Gambardella","year":"1998","unstructured":"Gambardella A, et al. Spinal muscular atrophy due to an isolated deletion of exon 8 of the telomeric survival motor neuron gene. Ann Neurol. 1998;44(5):836\u20139.","journal-title":"Ann Neurol"},{"issue":"3","key":"2406_CR38","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.4238\/2013.September.13.4","volume":"12","author":"WL Liu","year":"2013","unstructured":"Liu WL, et al. Molecular analysis of the SMN gene mutations in spinal muscular atrophy patients in China. Genet Mol Res. 2013;12(3):3598\u2013604.","journal-title":"Genet Mol Res"},{"issue":"4","key":"2406_CR39","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4103\/0022-3859.105451","volume":"58","author":"D Maiti","year":"2012","unstructured":"Maiti D, Bhattacharya M, Yadav S. Isolated exon 8 deletion in type 1 spinal muscular atrophy with bilateral optic atrophy: unusual genetic mutation leading to unusual manifestation? J Postgrad Med. 2012;58(4):294\u20135.","journal-title":"J Postgrad Med"},{"key":"2406_CR40","doi-asserted-by":"publisher","first-page":"117743","DOI":"10.1016\/j.cca.2023.117743","volume":"553","author":"J Bai","year":"2024","unstructured":"Bai J, et al. A high-fidelity long-read sequencing-based approach enables accurate and effective genetic diagnosis of spinal muscular atrophy. Clin Chim Acta. 2024;553:117743.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"2406_CR41","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1089\/gtmb.2014.0002","volume":"18","author":"JL Bai","year":"2014","unstructured":"Bai JL, et al. Subtle mutation detection of SMN1 gene in Chinese spinal muscular atrophy patients: implication of molecular diagnostic procedure for SMN1 gene mutations. Genet Test Mol Biomarkers. 2014;18(8):546\u201351.","journal-title":"Genet Test Mol Biomarkers"},{"issue":"2","key":"2406_CR42","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ajhg.2023.01.001","volume":"110","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Comprehensive SMN1 and SMN2 profiling for spinal muscular atrophy analysis using long-read PacBio HiFi sequencing. Am J Hum Genet. 2023;110(2):240\u201350.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2406_CR43","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1186\/s12967-025-06345-1","volume":"23","author":"S Li","year":"2025","unstructured":"Li S, et al. Targeted long-read sequencing facilitates effective carrier screening for complex monogenic diseases including spinal muscular atrophy, alpha-\/beta-thalassemia, 21-hydroxylase deficiency, and fragile-X syndrome. J Transl Med. 2025;23(1):307.","journal-title":"J Transl Med"},{"issue":"7","key":"2406_CR44","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S2352-4642(21)00100-0","volume":"5","author":"RS Finkel","year":"2021","unstructured":"Finkel RS, et al. Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study. Lancet Child Adolesc Health. 2021;5(7):491\u2013500.","journal-title":"Lancet Child Adolesc Health"},{"issue":"12","key":"2406_CR45","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S1474-4422(22)00339-8","volume":"21","author":"R Masson","year":"2022","unstructured":"Masson R, et al. Safety and efficacy of risdiplam in patients with type 1 spinal muscular atrophy (FIREFISH part 2): secondary analyses from an open-label trial. Lancet Neurol. 2022;21(12):1110\u20139.","journal-title":"Lancet Neurol"},{"issue":"7","key":"2406_CR46","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1038\/s41591-022-01867-3","volume":"28","author":"KA Strauss","year":"2022","unstructured":"Strauss KA, et al. Onasemnogene abeparvovec for presymptomatic infants with three copies of SMN2 at risk for spinal muscular atrophy: the Phase III SPR1NT trial. Nat Med. 2022;28(7):1390\u20137.","journal-title":"Nat Med"}],"container-title":["BMC Medical Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12920-026-02406-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12920-026-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:06:49Z","timestamp":1787018809000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12920-026-02406-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,6]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1186\/s12920-026-02406-6","relation":{},"ISSN":["1755-8794"],"issn-type":[{"value":"1755-8794","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,6]]},"assertion":[{"value":"14 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The need for ethical approval was waived by the Mayo Clinic Institutional Review Board (Mayo Clinic IRB). This project was reviewed using the Mayo Clinic Human Subjects Research Wizard and was determined to be Not Human Subjects Research (NHSR) by the Mayo Clinic Institutional Review Board (Mayo Clinic IRB) under 45 CFR 46.102. The Mayo Clinic IRB determined that full IRB approval was not required, and no IRB protocol number was assigned. All data were fully de-identified prior to analysis. The need for consent to participate was waived by the Mayo Clinic Institutional Review Board (Mayo Clinic IRB). All study procedures were performed in accordance with institutional guidelines and the ethical principles outlined in the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"129"}}